BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hassan ZK, Hafez MM, Mansor TM, Zekri AR. Occult HBV infection among Egyptian hepatocellular carcinoma patients. Virol J. 2011;8:90. [PMID: 21371325 DOI: 10.1186/1743-422x-8-90] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Marsella M, Ricchi P. Thalassemia and hepatocellular carcinoma: links and risks. J Blood Med 2019;10:323-34. [PMID: 31572038 DOI: 10.2147/JBM.S186362] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
2 Mathayan M, Jayaraman S, Kulanthaivel L, Suresh A. Inhibition studies of HBV DNA polymerase using seed extracts of Pongamia pinnata. Bioinformation 2019;15:506-12. [PMID: 31485136 DOI: 10.6026/97320630015506] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Rendon JC, Cortes-Mancera F, Restrepo-Gutierrez JC, Hoyos S, Navas MC. Molecular characterization of occult hepatitis B virus infection in patients with end-stage liver disease in Colombia. PLoS One 2017;12:e0180447. [PMID: 28686707 DOI: 10.1371/journal.pone.0180447] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
4 Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012;25:142-163. [PMID: 22232374 DOI: 10.1128/cmr.00018-11] [Cited by in Crossref: 91] [Cited by in F6Publishing: 58] [Article Influence: 10.1] [Reference Citation Analysis]
5 Elalfy H, Besheer T, Elhammady D, El Mesery A, Shaltout SW, Abd El-Maksoud M, Amin AI, Bekhit AN, Abd El Aziz M, El-Bendary M. Pathological characterization of occult hepatitis B virus infection in hepatitis C virus-associated or non-alcoholic steatohepatitis-related hepatocellular carcinoma. World J Meta-Anal 2020; 8(2): 67-77 [DOI: 10.13105/wjma.v8.i2.67] [Reference Citation Analysis]
6 Hernandez BY, Zhu X, Kwee S, Chan OT, Tsai N, Okimoto G, Horio D, McGlynn KA, Altekruse S, Wong LL. Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2013;22:2016-23. [PMID: 23983238 DOI: 10.1158/1055-9965.EPI-13-0397] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
7 Sosa-jurado F, Meléndez-mena D, Rosas-murrieta NH, Guzmán-flores B, Mendoza-torres MA, Barcenas-villalobos R, Márquez-domínguez L, Cortés-hernández P, Reyes-leyva J, Vallejo-ruiz V, Santos-lópez G, Chemin I. Effectiveness of PCR primers for the detection of occult hepatitis B virus infection in Mexican patients. PLoS ONE 2018;13:e0205356. [DOI: 10.1371/journal.pone.0205356] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ansari N, Makvandi M, Samarbaf-Zadeh AR. Hepatitis B virus genotyping among patients with cirrhosis. Jundishapur J Microbiol. 2015;8:e14571. [PMID: 25964845 DOI: 10.5812/jjm.14571] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Nishikawa H, Osaki Y. Clinical significance of occult hepatitis B infection in progression of liver disease and carcinogenesis. J Cancer 2013;4:473-80. [PMID: 23901347 DOI: 10.7150/jca.6609] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
10 Pondé RA. Molecular mechanisms underlying HBsAg negativity in occult HBV infection. Eur J Clin Microbiol Infect Dis. 2015;34:1709-1731. [PMID: 26105620 DOI: 10.1007/s10096-015-2422-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
11 Schiefelbein E, Zekri AR, Newton DW, Soliman GA, Banerjee M, Hung ChW, Seifeldin IA, Lo AC, Soliman AS. Hepatitis C virus and other risk factors in hepatocellular carcinoma. Acta Virol 2012;56:235-40. [PMID: 23043603 DOI: 10.4149/av_2012_03_235] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
12 Samal J, Kandpal M, Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev. 2012;25:142-163. [PMID: 22232374 DOI: 10.1128/cmr.00018-1125/1/142] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Elbahrawy A, Alaboudy A, El Moghazy W, Elwassief A, Alashker A, Abdallah AM. Occult hepatitis B virus infection in Egypt. World J Hepatol 2015; 7(12): 1671-1678 [PMID: 26140086 DOI: 10.4254/wjh.v7.i12.1671] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]